Feasibility of routine ultrasound-guided percutaneous transluminal angioplasty in the treatment of native arteriovenous fistula dysfunction.


Journal

The journal of vascular access
ISSN: 1724-6032
Titre abrégé: J Vasc Access
Pays: United States
ID NLM: 100940729

Informations de publication

Date de publication:
Sep 2021
Historique:
pubmed: 28 7 2020
medline: 18 11 2021
entrez: 28 7 2020
Statut: ppublish

Résumé

Stenosis is the main cause of arteriovenous fistula failure and is due to neointimal hyperplasia. Percutaneous transluminal angioplasty is the gold standard for patients with vascular access stenosis. The aim of the study was to evaluate the efficacy and safety of ultrasound-guided percutaneous transluminal angioplasty in the treatment of native arteriovenous fistula venous stenosis. The need for intervention was determined by physical examination and duplex ultrasound in 162 patients. All patients with failing or not maturing arteriovenous fistula were treated in the outpatient setting under ultrasound guidance. Procedural success was assessed with repeated post-procedural ultrasound examinations. All procedures were performed under local anesthesia by a single nephrologist and were performed in a single vascular laboratory, while follow-up ultrasound was performed in the dialysis unit of destination. Early technical success was obtained in 95.6% of cases (154 of 162). Complications occurred in 22 patients (13.5%) with no major complication requiring surgical or fluoroscopic endovascular intervention. Primary patency at 6 and 12 months was 84% and 69.8%, respectively. Risk factors for arteriovenous fistula failure/secondary percutaneous transluminal angioplasty were vascular access low blood flow rate and vintage, as well as the need for thrombolysis during the first percutaneous transluminal angioplasty. Ultrasound-guided percutaneous transluminal angioplasty is a valuable tool to treat vascular access stenosis.

Sections du résumé

BACKGROUND BACKGROUND
Stenosis is the main cause of arteriovenous fistula failure and is due to neointimal hyperplasia. Percutaneous transluminal angioplasty is the gold standard for patients with vascular access stenosis. The aim of the study was to evaluate the efficacy and safety of ultrasound-guided percutaneous transluminal angioplasty in the treatment of native arteriovenous fistula venous stenosis.
METHODS METHODS
The need for intervention was determined by physical examination and duplex ultrasound in 162 patients. All patients with failing or not maturing arteriovenous fistula were treated in the outpatient setting under ultrasound guidance. Procedural success was assessed with repeated post-procedural ultrasound examinations. All procedures were performed under local anesthesia by a single nephrologist and were performed in a single vascular laboratory, while follow-up ultrasound was performed in the dialysis unit of destination.
RESULTS RESULTS
Early technical success was obtained in 95.6% of cases (154 of 162). Complications occurred in 22 patients (13.5%) with no major complication requiring surgical or fluoroscopic endovascular intervention. Primary patency at 6 and 12 months was 84% and 69.8%, respectively. Risk factors for arteriovenous fistula failure/secondary percutaneous transluminal angioplasty were vascular access low blood flow rate and vintage, as well as the need for thrombolysis during the first percutaneous transluminal angioplasty.
CONCLUSION CONCLUSIONS
Ultrasound-guided percutaneous transluminal angioplasty is a valuable tool to treat vascular access stenosis.

Identifiants

pubmed: 32715906
doi: 10.1177/1129729820943076
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

739-743

Auteurs

Antonio Granata (A)

Nephrology and Dialysis Unit, "Cannizzaro" Hospital, Catania, Italy.

Rosario Maccarrone (R)

Nephrology and Dialysis Unit, "San Giovanni Di Dio" Hospital, Agrigento, Italy.

Luca Di Lullo (L)

Department of Nephrology and Dialysis, "L. Parodi-Delfino" Hospital, Roma, Italy.

Walter Morale (W)

Nephrology and Dialysis Unit, "Cannizzaro" Hospital, Catania, Italy.

Giovanni Giorgio Battaglia (GG)

Nephrology and Dialysis Unit, "Santa Marta e Santa Venera" Hospital, Acireale, Italy.

Pierpaolo Di Nicolò (P)

Nephrology and Dialysis Unit, "St. Maria della Scaletta" Hospital, Imola, Italy.

Antonio Bellasi (A)

Research, Innovation and Brand Reputation, ASST Papa Giovanni XXIII, Bergamo, Italy.

Francesco Pesce (F)

Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari "Aldo Moro," Bari, Italy.

Emad Khater (E)

Nephrology and Dialysis Unit, Shaikh Khalifa Medical City SKMC, Abu Dhabi, UAE.

Loreto Gesualdo (L)

Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari "Aldo Moro," Bari, Italy.

Antonio Basile (A)

Radiology Unit, University of Catania, Catania, Italy.

Maurizio Gallieni (M)

Nephrology and Dialysis Unit, Asst Fatebenefratelli Sacco, Milano, Italy.
"L. Sacco" Department of Biomedical and Clinical Sciences, University of Milan, Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH